跳至主要内容
临床试验/CTRI/2013/06/003780
CTRI/2013/06/003780已完成未知

An open label, monocentric, pilot study to evaluate the safety and efficacy of anti ageing product in healthy adult female subjects with skin type III to V. - NI

Sami Labs P Ltd0 个研究点目标入组 12 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Female adult subjects in general good health as determined from
  • a recent medical history.
  • 2. Subjects in the age group of 30 - 50 years (both ages inclusive).
  • 3. Subjects with Fitzpatrickâ??s skin types III, IV, and V.
  • 4. Subjects having visible fine lines and wrinkles, i.e,
  • Glabellar frownlines/Crowâ??s feet/nasolabial folds/forehead lines
  • and perioral wrinkles or few or all of them.
  • 5. Subjects who have not under gone any facial anti ageing
  • procedures (e.g. Botulinum toxin, dermal filler injections, laser
  • resurfacing) in the past 1 year.
  • 6. Subjects willing to discontinue use of topical anti ageing
  • products within 30 days before enrolling into study and not on
  • any oral anti ageing products such as anti oxidants,
  • green tea, etc 3 months before enrollment into study.
  • 7. Subject who are willing to abstain from spa treatments/facials
  • during the study Period.
  • 8. Subjects who have not undergone facial/spa treatment 2 weeks
  • before enrollment.
  • 9. Subjects willing to give a voluntary written informed consent
  • and agree to come for regular follow up.
  • 10. Subjects willing to abide by and comply with the study
  • 11. Subjects who have not participated in a similar investigation in
  • the past four weeks.
  • 12. Subjects who are willing not to participate in any other clinical
  • study during participation in the current study.
  • 13. In addition, female subjects selected for the study must:
  • Be using a medically acceptable form of birth control for the
  • duration of the study as judged by the investigator(s) Or
  • Be surgically sterile Or
  • Be post menopausal for at least 1 year
  • And have a negative urine pregnancy test at the screening visit

排除标准

  • 1.A known history or present condition of allergic
  • response/hypersensitivity to any cosmetic ingredients,pharmaceutical products or any ingredient of the IP.
  • 2. Female subjects with positive pregnancy test or not practicing contraception and nursing mothers.
  • 3. History of intense sun exposure.
  • 4. Presence of any underlying, clinically significant uncontrolled medical illness.
  • 5. Subject having active skin diseases
  • 6. Subject participating in any other cosmetic or therapeutic study.

研究者

发起方
Sami Labs P Ltd

相似试验

进行中(未招募)
1 期
A pilot study to assess the efficacy and safety of CBD oral solution in addition to standard treatment for pediatric subjects with Developmental and Epileptic EncephalopathyDevelopmental and Epileptic Encephalopathy (DEE)MedDRA version: 20.0Level: PTClassification code 10077380Term: Epileptic encephalopathySystem Organ Class: 10029205 - Nervous system disorders
EUCTR2019-001633-14-ITIRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA20
招募中
1 期
Pentosan Polysulfate Sodium (PPS) in subjects with mucopolysaccharidosis type I (MPS I)Mucopolysaccharidosis type I (MPS I)Metabolic and Endocrine - Metabolic disordersHuman Genetics and Inherited Disorders - Other human genetics and inherited disorders
ACTRN12620000823976Paradigm Biopharmaceuticals Pty Ltd10
尚未招募
不适用
A prospective study to assess the effect of adalimumab on cardiovascular biomarkers in participants with severe chronic plaque psoriasisChronic plaque psoriasisSkin - Dermatological conditionsInflammatory and Immune System - Other inflammatory or immune system disorders
ACTRN12613000419763Dr Anna Braue15
招募中
2 期
Study to evaluate the efficacy of Sucralfate as a healing agent in bed sores.
CTRI/2016/03/006745Internal FLUID Grant Christian Medical College Vellore30
撤回
1 期
A SINGLE CENTER OPEN-LABEL PILOT STUDY TO EVALUATE THE TOLERABILITY AND SAFETY OF A SYNTHETIC SOFT TISSUE IMPLANT MATERIAL IN THE SKIN OF NORMAL VOLUNTEERSTolerability and safety of a new synthetic soft tissue implant material for soft tissue augmentation in healthy volunteers.Surgery - Other surgery
ACTRN12607000223437COSMETREND PTY LTD8
Study to evaluate the safety and efficacy of anti... | 临床试验